PATENT CLAIM ANALYSIS

Application Number: 16138501
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["514", "772700"]

Abstract:
A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.

Claim (Index 5):
The biodegradable drug delivery composition of  claim 3 , wherein the pharmaceutically active principle is M53, acetaminophen, buprenorphine, risperidone, or ivermectin.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13340265', '13610979', '15114241', '13761419', '10101093']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7855001239144389
- 35 USC 102 Novelty (BERT): 0.6584392359482737
- Combined Prediction Score: 0.7727940351178224
- Mean Citation Score: 378.44954
- Max Citation Score: 840.1577
- Similarity Product: 588.2206502019228

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test